Terms: = Liver cancer AND TOP2A, TOP2, TP2A AND Treatment
33 results:
1. Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma.
Gao X; Ren X; Wang F; Ren X; Liu M; Cui G; Liu X
Sci Rep; 2024 Apr; 14(1):9509. PubMed ID: 38664521
[TBL] [Abstract] [Full Text] [Related]
2. Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma.
Wang C; Zhao Z; Zhao Y; Zhao J; Xia L; Xia Q
Commun Biol; 2024 Mar; 7(1):342. PubMed ID: 38503825
[TBL] [Abstract] [Full Text] [Related]
3. Role of top2a and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract] [Full Text] [Related]
4. cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the top2a coding sequence.
Ruan Y; Chen T; Zheng L; Cai J; Zhao H; Wang Y; Tao L; Xu J; Ji L; Cai X
Int J Biol Sci; 2023; 19(14):4608-4626. PubMed ID: 37781045
[TBL] [Abstract] [Full Text] [Related]
5. [Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma].
Wu YJ; Liu S; Tian YQ; Fan ZJ; Zhang L; Liu SY
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):869-876. PubMed ID: 37723070
[No Abstract] [Full Text] [Related]
6. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract] [Full Text] [Related]
7. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
Li C; Cui X; Li Y; Guo D; He S
Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
[TBL] [Abstract] [Full Text] [Related]
8. HBV-infected hepatocellular carcinoma can be robustly classified into three clinically relevant subgroups by a novel analytical protocol.
Cheng Z; Li L; Zhang Y; Ren Y; Gu J; Wang X; Zhao H; Lu H
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36736372
[TBL] [Abstract] [Full Text] [Related]
9. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract] [Full Text] [Related]
10. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
[TBL] [Abstract] [Full Text] [Related]
11. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract] [Full Text] [Related]
12. Signaling Pathways and Genes Associated with Hexavalent Chromium-Induced Hepatotoxicity.
Li X; Abdel-Moneim AE; Yang B
Biol Trace Elem Res; 2023 Apr; 201(4):1888-1904. PubMed ID: 35648283
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.
Wu ZH; Yang DL; Wang L; Liu J
Front Immunol; 2021; 12():793343. PubMed ID: 34925377
[TBL] [Abstract] [Full Text] [Related]
14. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
16. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
Liu R; Wang G; Zhang C; Bai D
World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
[TBL] [Abstract] [Full Text] [Related]
17. [Research of artificial intelligence-based clinical decision support system for primary hepatocellular carcinoma].
Yang J; Guo F; Lyu T; Yan LN; Wen TF; Yang JY; Wu H; Wang WT; Song JL; Xu H; Zhang QH
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(48):3870-3873. PubMed ID: 33371633
[No Abstract] [Full Text] [Related]
18.
Zeng Y; He H; Zhang Y; Wang X; Yang L; An Z
Biomed Res Int; 2020; 2020():4612158. PubMed ID: 32685486
[TBL] [Abstract] [Full Text] [Related]
19. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
[TBL] [Abstract] [Full Text] [Related]
20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract] [Full Text] [Related]
[Next]
